P2RY1 and encephalitis: Since there are many pharmacological agents available that target purinergic receptors in a specific manner, in vivo studies aimed at understanding the impact of purinergic receptor signaling in viral encephalitis have the potential to deliver  treatments for better outcomes of encephalitis.